Preclinical safety assessment considerations in vaccine development

Pharm Biotechnol. 1995:6:61-79. doi: 10.1007/978-1-4615-1823-5_3.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Design
  • Drug Evaluation, Preclinical
  • Humans
  • Vaccines / adverse effects*
  • Vaccines, Attenuated / adverse effects
  • Vaccines, Inactivated / adverse effects
  • Vaccines, Synthetic / adverse effects

Substances

  • Vaccines
  • Vaccines, Attenuated
  • Vaccines, Inactivated
  • Vaccines, Synthetic